Bavaria is the premier gateway to Europe’s healthcare market. More than 900 life sciences companies—from niche startups to leading names such as Siemens Healthineers, GE Healthcare and Amgen—work each day to develop globally significant advances in medical devices, digital health and biotechnology.
Alongside more than 400 hospitals, 28 major universities and numerous health-related research institutions, Bavaria’s network of innovators has produced Germany’s strongest medical drug pipeline, accounts for more than 40% of the country’s medical-related patents and is investing billions in the future of digital health.
From a strong pharmaceutical supplier network and Europe’s highest number of biotechnology startups, to 70,000 medical device professionals and leading companies in digital healthcare, Bavaria is a world-class center for health-related science and technology.
Germany’s largest life science campus is located in greater Munich, where you will find industry heavyweights that include Roche Diagnostics, Sandoz, GE Healthcare, Amgen, Thermo Fischer Scientific, Baxter, Celgene, Novartis, Bristol-Myers Squibb, GSK and Daiichi-Sankyo. In addition, there is a dense ecosystem of world-renowned institutions, including three Max Planck Institutes, leading university clinics and all six of Germany’s national health centers. Bavaria is also the place where a deeply-connected healthcare industry and supportive research community coalesce to create many exciting collaboration opportunities: BioM in Munich, Germany’s leader in personalized medicine and immunotherapy; Medical Valley in Nuremberg-Erlangen, Germany’s top medical device and digital health hub; and the European Institute of Innovation and Technology in Healthcare (EIT Health) in Munich, which is investing $2 Billion over a decade in digital health entrepreneurship.
Bavaria’s four life sciences cluster regions (Munich, Nuremberg, Regensburg and Wuerzburg) contain some of Europe’s finest research and technical universities, attracting world-leading scientists and producing sought after top-level graduates. Among them are two elite universities—Ludwig-Maximilians University (LMU) and Technical University of Munich (TUM), both in Munich. TUM has the distinction of being Europe’s #1 center for innovation and business creation.
Bavaria’s local and global leaders in medical technology account for 42% of all German initial patent filings for diagnosis, surgery and identification technologies, and cover a broad range of applications: intelligent sensors, diagnostic imaging, implants, aging in place and healthcare IT. The biotechnology sector excels in red biotechnology with the development of therapeutics and diagnostics, and is award-winning in personalized medicine. Bavaria also has Germany’s strongest medical drug pipeline with 125 drugs in development and eight drugs (derived from Bavarian SMEs) on the market. Universities and world-renowned private institutions like the Helmholtz Association and the Max Planck and Fraunhofer Societies contribute to the culture of innovation that make Bavaria the place for biotech startups and global players alike to flourish and innovate.
Feel free to contact one of our U.S. representatives directly, or request a meeting using the form below.